Getting Wegovy requires a prescription from a licensed healthcare provider, meeting specific weight-related criteria, and navigating insurance or out-of-pocket costs that can be significant. The process typically involves a medical evaluation, possible lab work, and a gradual dose increase over several months before you reach the full maintenance dose. Here’s what each step looks like in practice.
Who Qualifies for Wegovy
The FDA approved Wegovy for adults with a BMI of 30 or higher (classified as obesity) or a BMI of 27 or higher if they also have at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol. It’s also approved for adolescents aged 12 and older whose BMI falls at or above the 95th percentile for their age and sex.
These are the minimum medical criteria for a prescription, but your insurance company may set the bar higher. Aetna, for example, has required documentation that a patient participated in a structured weight management program (including diet changes, exercise, and behavioral counseling) for at least six months before approving coverage. Other insurers have similar requirements. Even if you clearly qualify on paper, expect to provide records showing you’ve already tried lifestyle-based approaches.
Where to Get a Prescription
Any licensed doctor, physician assistant, or nurse practitioner can prescribe Wegovy. You don’t need to see an obesity specialist or endocrinologist, though those providers will be most familiar with the medication. During your visit, the provider will review your medical history, check your weight and BMI, and discuss your current diet and activity level. Some providers will order blood work to screen for thyroid issues, kidney function, or blood sugar levels before writing the prescription.
Telehealth is a legitimate option if you prefer not to go in person. Novo Nordisk’s own patient support site, NovoCare, now directs patients to telehealth providers like Form Health and 9amHealth, both of which can evaluate you and write prescriptions. Other platforms such as Noom Med, Calibrate, and LifeMD also prescribe Wegovy, though most require lab work at a local facility before your virtual appointment. Expect the intake process to take a few days to a couple of weeks depending on the platform.
What the Dosing Schedule Looks Like
You won’t start on the full dose. Wegovy uses a gradual titration schedule to reduce side effects, particularly nausea. You’ll begin at 0.25 mg once per week, then step up every four weeks through 0.5 mg, 1 mg, and 1.7 mg before reaching the maintenance dose of 2.4 mg. This ramp-up takes about 16 to 17 weeks total.
Each dose level comes as a prefilled pen with an integrated needle. You inject it once a week under the skin of your abdomen, thigh, or upper arm. The pens are designed so you don’t need to measure or draw up the medication yourself, which eliminates one of the major safety risks associated with compounded alternatives (more on that below).
Insurance Coverage and Prior Authorization
Many insurance plans cover Wegovy, but almost all require prior authorization, meaning your provider has to submit clinical documentation proving you meet the plan’s criteria before the pharmacy can fill your prescription. This process can take anywhere from a few days to a few weeks.
For initial approval, insurers typically want to see your BMI, any relevant diagnoses (diabetes, hypertension, etc.), and evidence of previous weight management efforts. Renewal is another hurdle. Aetna’s policy, which is representative of many major insurers, requires proof that you’ve lost at least 5% of your baseline body weight after three months on the maintenance dose, or that you’re maintaining a previous 5% loss. If you don’t hit that threshold, coverage can be denied on renewal.
If your insurance doesn’t cover Wegovy at all, you’re looking at a retail price of around $1,349 per 28-day supply. Novo Nordisk offers a manufacturer savings card that knocks up to $1,001 off the retail price, potentially bringing your cost down to as low as $0 with insurance or around $499 without it. The savings card is available to patients with or without insurance, though the exact discount depends on your plan.
Filling Your Prescription
Wegovy was in shortage for much of 2023 and 2024, but the FDA has determined that the shortage is resolved and all dose strengths are currently available. That said, not every local pharmacy keeps Wegovy in stock consistently, especially the lower starter doses that have less demand.
If your pharmacy can’t fill the prescription, you have two practical options. First, ask your pharmacist to order it, which usually takes a few business days. Second, use a mail-order pharmacy. Novo Nordisk runs NovoCare Pharmacy (dispensed through CoAssist Pharmacy), which ships Wegovy directly to your home at no delivery cost. Your provider can send the prescription there electronically, and you’ll receive a text confirmation once it’s processing. Many insurance plans also have their own preferred mail-order pharmacies for specialty medications, which may offer lower copays.
Why Compounded Semaglutide Is Risky
During the shortage, compounding pharmacies began producing their own versions of semaglutide, the active ingredient in Wegovy. These products are still widely available online, often at lower prices, but they carry real safety risks that are worth understanding before you consider them.
Compounded semaglutide does not go through FDA review for safety, quality, or effectiveness. Unlike the prefilled Wegovy pen, compounded versions typically come in multi-dose vials that require you to draw up and measure your own dose using a syringe. The FDA has received reports of patients accidentally injecting 5 to 20 times more than their intended dose because of confusion over unit conversions or varying concentrations between products. Some of these overdoses led to hospitalization, with symptoms including severe nausea, vomiting, fainting, dehydration, acute pancreatitis, and gallstones.
There’s another concern beyond dosing errors. Some compounders use salt forms of semaglutide (such as semaglutide sodium or semaglutide acetate) rather than the base form used in FDA-approved products. These are technically different active ingredients, and the FDA has stated it’s not aware of any legal basis for using them in compounding. Some compounders also add other ingredients like vitamin B-12 or L-carnitine. The safety of combining semaglutide with these additives has not been studied.
How to Move Through the Process Efficiently
The biggest delays most people experience are insurance-related, so front-loading the paperwork helps. Before your appointment, gather any documentation of past weight loss efforts: gym memberships, dietitian visits, records from a structured program. If your primary care provider has notes about weight-related counseling in your chart over the past six months or more, that counts too. The more complete the record your provider can submit with the prior authorization, the less likely you’ll face a denial or a request for additional information.
If your insurance denies coverage, you have the right to appeal. Your provider’s office can often handle the first level of appeal by submitting additional clinical justification. Many patients who are denied on the first pass get approved on appeal, particularly if they have documented comorbidities. If the appeal fails, the manufacturer savings card at least brings the out-of-pocket cost closer to $500 per month rather than the full $1,349.
From your first appointment to actually injecting the medication, expect a timeline of one to four weeks depending on whether you need lab work, how quickly prior authorization goes through, and pharmacy availability. The full dose escalation then takes about four months before you’re on the maintenance dose that clinical trials used to measure weight loss results.